ObsEva (NASDAQ:OBSV) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a report issued on Sunday morning. The brokerage issued a hold rating on the stock.

ObsEva Price Performance

ObsEva has a 52-week low of $0.08 and a 52-week high of $2.14. The company has a market cap of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68. The business’s 50-day simple moving average is $0.01.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.